RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ACRO Biomedical Co Stock

ACRO Biomedical Co Equity 2024

ACRO Biomedical Co Equity

490,000.01 USD

Ticker

ACBM

ISIN

US0048921052

In 2024, ACRO Biomedical Co's equity was 490,000.01 USD, a -23.44% increase from the 639,999.99 USD equity in the previous year.

ACRO Biomedical Co Aktienanalyse

What does ACRO Biomedical Co do?

ACRO Biomedical Co Ltd is a leading company in biomedical technology based in Taipei, Taiwan. The company was established in 2006 and has since successfully established itself in the global market for biomedical products and technologies. The company's vision is to improve people's lives and promote health worldwide through innovative and high-quality products and solutions. Business model: ACRO Biomedical Co Ltd specializes in the development, manufacturing, and marketing of biomedical products and technologies. The company has three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology. Each division focuses on developing products and solutions tailored to the needs of patients and medical professionals. Regenerative Medicine: ACRO Biomedical Co Ltd is a leading provider of regenerative biomedical products. Under this division, the company develops innovative solutions for tissue regeneration, such as bioimplants made from natural tissues and biomaterials to repair or restore damaged tissue. These products are used for the treatment of injuries, chronic diseases, and degenerative conditions. Additionally, ACRO Biomedical Co Ltd has also developed solutions for cosmetic and aesthetic applications. Wound Care: ACRO Biomedical Co Ltd's wound care division specializes in developing products and solutions that help accelerate wound healing, prevent infections, and reduce the risk of complications. The company offers a wide range of products, including antimicrobial and moist wound dressings, which are used for the treatment of acute and chronic wounds such as burns, abrasions, and diabetic foot ulcers. Surgical Technology: ACRO Biomedical Co Ltd's surgical technology division provides healthcare professionals with a wide range of surgical products for various applications, including neurosurgery, plastic surgery, and general surgery. The innovative products offered by ACRO Biomedical Co Ltd for surgical applications include cutting tools, implants, and instruments for minimally invasive procedures. Products: ACRO Biomedical Co Ltd offers a wide range of products for various applications and medical specialties. Some of the company's key products include: - ACL-Bioimplant: A bioimplant for cruciate ligament repair made from human cartilage and biomaterials. - ACRO-CAF: A bone grafting material for bone transplantation. - ACRO-Mixtop: A wound healing agent for the treatment of burns, abrasions, and chronic wounds. - ACRO-OSTEOT: A surgical bone drill for orthopedics and neurosurgery. - ACRO-BioSIS: A tissue adhesive for surgical applications. Summary: ACRO Biomedical Co Ltd is a leading company in biomedical technology that offers innovative solutions for the preservation and restoration of people's health. With its three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology, the company provides a wide range of products and solutions for medical professionals and patients. The company's products are marketed worldwide and are known for their quality, reliability, and effectiveness. ACRO Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing ACRO Biomedical Co's Equity

ACRO Biomedical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ACRO Biomedical Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating ACRO Biomedical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

ACRO Biomedical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in ACRO Biomedical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about ACRO Biomedical Co stock

What is the equity of ACRO Biomedical Co this year?

ACRO Biomedical Co has equity of 490,000.01 USD this year.

What was the equity of ACRO Biomedical Co compared to the previous year?

The equity of ACRO Biomedical Co has increased/decreased by -23.44% decreased compared to the previous year.

What impact does a high equity have on investors of ACRO Biomedical Co?

A high equity is advantageous for investors of ACRO Biomedical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of ACRO Biomedical Co?

A low equity can be a risk for investors of ACRO Biomedical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of ACRO Biomedical Co affect the company?

An increase in equity of ACRO Biomedical Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of ACRO Biomedical Co affect the company?

A reduction in equity of ACRO Biomedical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of ACRO Biomedical Co?

Some factors that can affect the equity of ACRO Biomedical Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of ACRO Biomedical Co so important for investors?

The equity of ACRO Biomedical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can ACRO Biomedical Co take to change the equity?

To change equity, ACRO Biomedical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does ACRO Biomedical Co pay?

Over the past 12 months, ACRO Biomedical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ACRO Biomedical Co is expected to pay a dividend of 0 USD.

What is the dividend yield of ACRO Biomedical Co?

The current dividend yield of ACRO Biomedical Co is .

When does ACRO Biomedical Co pay dividends?

ACRO Biomedical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ACRO Biomedical Co?

ACRO Biomedical Co paid dividends every year for the past 0 years.

What is the dividend of ACRO Biomedical Co?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ACRO Biomedical Co located?

ACRO Biomedical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von ACRO Biomedical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ACRO Biomedical Co from 7/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.

When did ACRO Biomedical Co pay the last dividend?

The last dividend was paid out on 7/29/2024.

What was the dividend of ACRO Biomedical Co in the year 2023?

In the year 2023, ACRO Biomedical Co distributed 0 USD as dividends.

In which currency does ACRO Biomedical Co pay out the dividend?

The dividends of ACRO Biomedical Co are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ACRO Biomedical Co

Our stock analysis for ACRO Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ACRO Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.